Distribution Agreement Constitutes an “Offer for Sale” Under Pre-AIA 35 U.S.C. § 102(b)
February 21, 2018
Authored and Edited by Pier D. DeRoo; Lillian R. Phares; Elizabeth D. Ferrill
Following the court’s en banc decision that a contract manufacturing arrangement did not give rise to an on-sale bar, the Medicines Co. v. Hospira, Inc. appeal returned to the original Federal Circuit panel on remand. 827 F.3d 1363 (Fed. Cir. 2016) (en banc). The panel proceeded to analyze the on-sale bar effects of a particular distribution agreement between MedCo and its product distributor, ICS, before the § 102(b) critical date.
Reversing the district court, the Federal Circuit held that the particular distribution agreement at issue qualified as an “offer for sale” under § 102(b). First, the particular agreement stated that MedCo “now desire[d] to sell the Product” and ICS “desire[d] to purchase and distribute the Product.” Second, the particular agreement specified a “commercial price” for any sales. Third, the particular agreement provided for a transfer of title upon product delivery to ICS. These terms in the particular agreement led the court to conclude that a commercial offer for sale in this case had occurred. But because the record did not reflect any determination of whether the distribution agreement covered the patented invention, rather than a previous version of the pharmaceutical product, the Federal Circuit remanded to the district court to address this issue in the first instance.
Want to learn more? Click here for additional commentary about this case from Finnegan’s “Last Month at the Federal Circuit” podcast series.
Copyright © 2018 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
10th Annual Georgia Asian Pacific American Bar Association Gala
May 29, 2024
Atlanta
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.